Evgenia Rousaki

Title: Evgenia Rousaki: Innovator in Pharmaceutical Chemistry

Introduction

Evgenia Rousaki is a prominent inventor based in Basel, Switzerland. She has made significant contributions to the field of pharmaceutical chemistry, holding a total of 3 patents. Her work focuses on the development of innovative crystalline forms of pharmaceutical compounds.

Latest Patents

Rousaki's latest patents include specific crystalline forms of N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-5-yl)pyridine-3-carboxamide. These inventions describe methods for preparing these crystalline forms, as well as pharmaceutical compositions that incorporate them. The applications of these inventions are aimed at treating various diseases, showcasing her commitment to advancing medical science.

Career Highlights

Evgenia Rousaki is currently employed at Novartis AG, a leading global healthcare company. Her role involves extensive research and development in the pharmaceutical sector, where she applies her expertise to create innovative solutions for health challenges.

Collaborations

Throughout her career, Rousaki has collaborated with notable colleagues, including Stephanie Kay Dodd and Arnaud Grandeury. These partnerships have enhanced her research and contributed to the success of her inventions.

Conclusion

Evgenia Rousaki is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable innovations. Her contributions continue to impact the field positively, and her patents reflect her dedication to improving healthcare solutions.